It is time you stop underestimating the goodness of cannabis, after all it is naturally found and is bound to posses qualities that other herbal items do. It has been found that some cancer patients do not respond well to medications like morphine, and to make their treatment more fruitful, researchers are testing a cannabis mouth spray that will have the ability to relieve pain in cancer patients.
The spray is called Sativex, and it is being monitored as affects of medicinal cannabis in people with cancer and multiple sclerosis mounts. Dr Brian Le, who is a palliative care specialist at the Royal Melbourne Hospital, said four Australian hospitals were participating in the study which involved about 300 patients in 20 locations around the world.
The spray Sativex is administered as a metered dose oro-mucosal spray; each 100µL of the spray contains 2.7mg THC and 2.5mg CBD. The spray formulation is standardised by the composition of it and the dose. The components that make up Sativex have been shown to bind to cannabinoid receptors that are distributed throughout the central nervous system and in immune cells.
Read more articles on Health News